Overview
International law firm McDermott Will & Emery represented Future Health ESG Corp. (NASDAQ: FHLT), a special purpose acquisition company, in its acquisition of Excelera DCE, a leading Accountable Care Organization and AI Platform. This merger supports the expansion of Excelera’s science-driven approach to managing care for seniors and is expected to be listed on NASDAQ under “XLRA”.
- The transaction was announced on June 14, 2022.
- The deal values Excelera at $459 million, the companies said, adding it is expected to provide up to $282 million to accelerate expansion of Excelera’s network. Upon completion of the transaction, the combined company is expected to operate as Excelera Health, Inc. and Excelera’s existing management team will continue to lead the Company following the transaction.
- The McDermott team was led by Ari Edelman, Jeremy Earl and Sunyi Snow and included Matt Perreault, Jason Kramer, Caroline Sandy, Yuxin Jin, Emily Curran, Ryan Houseal, Marchan Clark, Kwabena Yeboah, Cristell Fortune, Li Wang, Steve Hadjilogiou and Michelle Strowhiro.
- Read Future Health and Excelera’s combined press release here.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
